Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.1 (
aspartate aminotransferase
)
21,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate the relationships between whole-body vibration and changes in wakefulness, We measured the change of a subjective wakefulness level and electroencephalogram (EEG). Subjects are ten healthy male university students. The subjects were exposed to whole-body vibration with frequency (10 Hz) and acceleration level (0.6 ms(-2) r.m.s.) for 12 min in the seated position. Subjective wakefulness level was evaluated using the questionnaire of VASS (Visual Analog Sleepiness Scale) and
KSS
(The Kwansei Gakuin Sleepiness Scale). For the electroencephalogram (EEG) measurement,
AAT
(Alpha Attenuation Test) which repeats three times each opened and closed eye for 1 min was conducted. Wakefulness levels were defined as the ratio of mean alpha-wave power during eyes closed versus eyes opened. VASS and
KSS
increased and subjective level of wakefulness decreased from pre- to post exposure in all subjects, regardless of vibration exposure. The objective wakefulness levels of
AAT
were reduced at the post-exposure test in all subjects. In the case with exposure to whole-body vibration was a significant difference from the case without exposure to whole-body vibration. It is suggested that a short-term exposure to whole-body vibration may cause a reduction of wakefulness level.
...
PMID:Effects of short-term exposure to whole-body vibration on wakefulness level. 1748 65